37 results on '"Bry-Gauillard, H."'
Search Results
2. Random antral follicle count performed on any day of the menstrual cycle has the same predictive value as AMH for good ovarian response in IVF cycles
3. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF
4. O-068 The BISTIM study: first RCT comparing dual ovarian stimulation on the same cycle (duostim) vs 2 conventional ovarian stimulations in poor ovarian responders undergoing IVF
5. P–599 random antral follicle count, performed at any day of the menstrual cycle, demonstrates the same predictive value for ovarian response in in vitro fertilization cycles
6. Timing of FSH administration for ovarian stimulation in normo-ovulatory women: comparison of an early or a mid follicular phase initiation of a short-term treatment
7. A Comprehensive Endocrine Description of Kennedy’s Disease Revealing Androgen Insensitivity Linked to CAG Repeat Length
8. Beneficial effects of GnRH agonist administration prior to ovarian stimulation for patients with a short follicular phase
9. Faut-il traiter par metformine les femmes infertiles présentant un syndrome des ovaires polykystiques ?
10. Bénéfices et risques de la stimulation ovarienneen vue d’inséminations intra-utérines
11. Inhibine B (IB) et AMH circulantes : relations avec la morphologie ovarienne chez 72 femmes avec hypogonadisme hypogonadotrophique isolé (HHI)/Kallmann (KS). Effets de la FSH recombinante (FSHr)
12. Congenital hypogonadotropic hypogonadism in females: Clinical spectrum, evaluation and genetics
13. Androgen receptor gene mutation and partial androgen insensitivity syndrome: birth after testicular sperm extraction and ICSI
14. IGFBP-1 inhibits EGF mitogenic activity in cultured endometrial stromal cells
15. Primary Amenorrhea Due to Constant High Progesterone Level Revealing a Leydig Cell Ovarian Tumor
16. Transdermal testosterone application: Effects on the ovarian responsiveness to FSH for low responders to controlled hyperstimulation
17. Complete regression of a major hyperprolactinaemia after renal transplantation
18. Case report. Complete regression of a major hyperprolactinaemia after renal transplantation.
19. Case report. Complete regression of a major hyperprolactinaemia after renal transplantation
20. Should infertile women with polycystic ovarian syndrome be treated with metformine?
21. Estradiol levels in men with congenital hypogonadotropic hypogonadism and the effects of different modalities of hormonal treatment
22. Prospective multicenter observational real-world study to assess the use, efficacy and safety profile of follitropin delta during IVF/ICSI procedures (DELTA Study).
23. Late and brief recovery of ovarian function 7 years after Mitotane cessation.
24. Live birth after in-vitro maturation of oocytes in a patient with specific ovarian insufficiency caused by long-term mitotane treatment for adrenocortical carcinoma.
25. Comparison of stimulated versus modified natural cycles for endometrial preparation prior to frozen embryo transfer: a randomized controlled trial.
26. Anti-Müllerian Hormone and Ovarian Morphology in Women With Isolated Hypogonadotropic Hypogonadism/Kallmann Syndrome: Effects of Recombinant Human FSH.
27. Kallmann syndrome with FGFR1 and KAL1 mutations detected during fetal life.
28. Secondary amenorrhoea associated with high serum 17-hydroxyprogesterone levels revealing a heterozygous CYP21A2 mutation in a woman with Addison disease.
29. New NOBOX mutations identified in a large cohort of women with primary ovarian insufficiency decrease KIT-L expression.
30. Ovarian macrocysts and gonadotrope-ovarian axis disruption in premenopausal women receiving mitotane for adrenocortical carcinoma or Cushing's disease.
31. Mitotane for 21-hydroxylase deficiency in an infertile man.
32. Testicular histological and immunohistochemical aspects in a post-pubertal patient with 5 alpha-reductase type 2 deficiency: case report and review of the literature in a perspective of evaluation of potential fertility of these patients.
33. Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.
34. Estradiol levels in men with congenital hypogonadotropic hypogonadism and the effects of different modalities of hormonal treatment.
35. Primary amenorrhea revealing an occult progesterone-secreting ovarian tumor.
36. Comparison of recombinant and urinary follicle-stimulating hormone preparations in short-term gonadotropin releasing hormone agonist protocol for in vitro fertilization-embryo transfer.
37. Comparison of the effectiveness of recombinant and urinary FSH preparations in the achievement of follicular selection in chronic anovulation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.